Showing all 8 results
Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. Stability is a key factor in our formulation.
Active Ingredient Strength (Standard) Role Artesunate IP/BP 50 mg Pediatric / Initial Dose Artesunate IP/BP 100 mg Adult Standard Dose Artesunate IP/BP 200 mg High Strength (Combination Protocols) Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is critical to mask the intensely bitter taste of the drug. Note: Dosing is often calculated based on the “Base” content.
Active Ingredient (Salt) Equivalent Base Primary Role Chloroquine Phosphate USP/BP 250 mg ~ 155 mg Base Prophylaxis / Maintenance Chloroquine Phosphate USP/BP 500 mg ~ 310 mg Base Acute Malaria Treatment Excipients Q.S. Starch / Magnesium Stearate Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Quinine Sulphate Tablets
FreeGlaquine
Quinine Sulphate Tablets BP 300 mg
Eac Sugarcoated tablet contains :
Quinine Sulphate BP 300 mgUsage: – treat malaria caused by mosquito bites
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc










